Aclarion

ACON · NASDAQ

$1.97+$0.01 (+0.51%)TodayMarket closed · Oct 21, 4:07 AM ET

Prev close $1.96

Latest news

Press releaseOct 20, 7:00 AM ETGlobe Newswire
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
Press releaseOct 13, 7:00 AM ETGlobe Newswire
Aclarion to Present at the 20th Annual LD Micro Main Event
Press releaseSep 29, 7:00 AM ETGlobe Newswire
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Press releaseJul 29, 7:00 AM ETGlobe Newswire
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Press releaseJun 9, 7:00 AM ETGlobe Newswire
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Press releaseJun 3, 6:00 AM ETGlobe Newswire
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
Press releaseMay 28, 2:49 PM ETGlobe Newswire
Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal
Press releaseMay 5, 6:00 AM ETGlobe Newswire
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
Press releaseApr 30, 6:00 AM ETGlobe Newswire
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
Press releaseApr 28, 6:00 AM ETGlobe Newswire
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
Press releaseApr 22, 8:30 AM ETGlobe Newswire
Aclarion Announces $2.5 Million Stock Repurchase Plan
Press releaseApr 16, 6:47 AM ETGlobe Newswire
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Press releaseApr 14, 8:00 AM ETGlobe Newswire
Aclarion Receives Pinnacle Award for AI Innovation
Press releaseApr 8, 8:00 AM ETGlobe Newswire
Aclarion Announces Agreement with Weill Cornell Medicine
Press releaseApr 7, 8:00 AM ETGlobe Newswire
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Press releaseMar 19, 6:00 AM ETGlobe Newswire
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
Press releaseMar 17, 6:00 AM ETGlobe Newswire
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
Press releaseMar 12, 6:00 AM ETGlobe Newswire
Aclarion CEO Brent Ness to Attend LSI USA 2026
Press releaseFeb 5, 6:00 AM ETGlobe Newswire
Aclarion Publishes 2026 Shareholder Letter from the Chairman
Press releaseFeb 3, 6:00 AM ETGlobe Newswire
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
NewsJan 13, 10:51 AM ETLekha Gupta
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
NewsJan 9, 10:25 AM ETAvi Kapoor
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
NewsJan 9, 8:08 AM ETAvi Kapoor
WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-Market Session
NewsJan 9, 4:46 AM ETAvi Kapoor
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
NewsJan 8, 12:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Press releaseJan 8, 9:32 AM ETGlobe Newswire
Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape
NewsJan 8, 7:35 AM ET
Market-Moving News for January 8th
NewsJan 8, 7:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseOct 14, 6:09 AM ETGlobe Newswire
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
NewsOct 14, 5:45 AM ETAvi Kapoor
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Press releaseAug 5, 6:00 AM ETGlobe Newswire
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
NewsJul 28, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsApr 11, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsApr 1, 6:28 PM ETChris Katje
EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?
NewsMar 26, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMar 26, 8:11 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMar 14, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseMar 10, 9:16 AM ETGlobe Newswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
NewsJan 15, 9:30 AM ET
Aclarion Announces Pricing Of $14.4M Public Offering Of Common Stock and Warrants

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Aclarion to Present at the 20th Annual LD Micro Main Event

Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Aclarion Announces $2.5 Million Stock Repurchase Plan

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Receives Pinnacle Award for AI Innovation

Aclarion Announces Agreement with Weill Cornell Medicine

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

Aclarion CEO Brent Ness to Attend LSI USA 2026

Aclarion Publishes 2026 Shareholder Letter from the Chairman

Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout

Dow Edges Higher; US Economy Adds 50,000 Jobs In December

WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's Intraday Session

Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape

Market-Moving News for January 8th

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst

Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments

Aclarion Announces Pricing Of $14.4M Public Offering Of Common Stock and Warrants